Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study
Background: We report long-term safety and immunogenicity of Takeda's tetravalent dengue vaccine candidate (TAK-003) in healthy children and adults living in dengue-endemic areas in Puerto Rico, Columbia, Singapore, and Thailand. Methods: In part 1 of this phase 2, randomized, placebo-controlle...
Saved in:
Main Authors: | Chukiat Sirivichayakul, Elizabeth A. Barranco-Santana, Inés Esquilín Rivera, Jennifer Kilbury, Marsha Raanan, Astrid Borkowski, Athanasia Papadimitriou, Derek Wallace |
---|---|
Other Authors: | Faculty of Tropical Medicine, Mahidol University |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/74605 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study
by: Sirivichayakul C.
Published: (2023) -
Efficacy of a tetravalent dengue vaccine in healthy children and adolescents
by: Shibadas Biswal, et al.
Published: (2020) -
Characterization of a candidate tetravalent vaccine based on 2’-O-methyltransferase mutants
by: Züst R., et al.
Published: (2019) -
Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults
by: Scott Kitchener, et al.
Published: (2018) -
Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
by: Arunee Sabchareon, et al.
Published: (2018)